Moderna seeks approval for updated COVID booster Moderna on Tuesday said it submitted a request for the Food and Drug Administration (FDA) to authorize an updated version of its COVID-19 vaccine targeting the latest omicron subvariants. The application comes ahead of a fall booster shot ...
CAMBRIDGE, MA / ACCESSWIRE / April 19, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced new clinical data on its bivalent COVID-19 booster platform including data on the Company's first ...
Moderna launches COVID booster campaignHollan, MikePatient Care (Online)
Moderna has further expanded its deal with Lonza this week, with an agreement to establish a production line at Lonza’s Geleen site in the Netherlands. Once operational (expected by the end of the year), the line will produce an additional 300 million doses ofModerna’s updated booster vari...
A new report accuses American drugmaker Moderna of prioritizing profits from COVID-19 vaccines by keeping poor countries waiting. The New York Times says the vaccine maker has sold most of its doses to wealthier nations. Only one million doses have gone to low-income countries...
Thus, additional booster doses may be needed to ensure individuals remain adequately protected, said the company. The FDA is set to convene its advisory committee of vaccine experts in April to deliberate how to arrange COVID-19 booster shots, including whether and when those boosters may be ne...
The art of COVID-19 communication Call for global biodiversity agreementModerna said it is looking at whether a booster shot – either of its existing vaccine or of a new shot designed to protect against the South Africa variant – could be made available in future if evidence...
Moderna announced on Thursday that it had asked the Food and Drug Administration (FDA) for emergency use authorization for a second booster dose of its COVID-19 vaccine for all adults. Moderna said in a press release that it requested the authorization f
In the U.S., booster shots will soon be available for those who got the Moderna and Pfizer COVID-19 vaccines. But for those who got the single-shot Johnson & Johnson, many are still wondering what’s next. Mark Niu reports. Check out The China Report, our new weekly...
Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing Covid-19.